Summary:
What is the Liberatus study?
The Liberatus study is a clinical research study for those with lactose intolerance. The purpose of this study is to determine the effectiveness, durability, safety, and tolerability of the study drug (RP-G28) when compared to placebo to treat the symptoms of lactose intolerance (your ability to eat lactose containing foods, like dairy, without discomfort).
Who can participate in the study?*
You may be able to participate in this study if you meet these criteria:
- 18-75 years of age
- Current or recent history of intolerance to milk and other dairy products for at least 1 month
- No other gastrointestinal disorders that could interfere with the study, including Crohn’s disease, irritable bowel syndrome, inflammatory bowel disease, ulcerative colitis, Celiac disease, chronic constipation
- Agree to stop taking all other treatments and products used for lactose intolerance (e.g., Lactaid®, dietary supplements, herbal remedies) during the study
- Agree to abstain from consuming dairy products during certain days of the study and to include dairy products at other times
- Must be willing to complete multiple electronic diary questionnaires at specific time points (sometimes daily, sometimes weekly) during the study. The diary will capture your daily lactose consumption (diet), any symptoms you may experience, questions about how you are doing, as well as study drug dosing (when applicable).
*Other criteria will apply
Qualified Participants May Receive:
You will receive compensation for time and travel.